EVER · EverQuote, Inc.

Current Thesis

EverQuote’s insurance-advertising growth thesis now requires a close above the $27.87 market high before a weekly close below $23.82 breaks the structure, with third-quarter results testing the revenue expansion. The measured change since the August 30 assessment is weaker price: the September 11, 2026 adjusted close was $23.98, compared with $25.66 on August 28. The September 10 management-conference date has also elapsed; it is no longer an upcoming catalyst. Company conference announcement, August 5.

The underlying story remains the expansion reported on August 3: second-quarter revenue reached $195.1 million, up 25% year over year, and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) reached $30.1 million. Management forecast third-quarter revenue of $198–208 million and adjusted EBITDA of $28–31 million. Those are company projections, not measured third-quarter outcomes. Second-quarter results.

The lifecycle assessment is an inference: the narrative is maturing — the August 3 earnings expansion and August 24 JPMorgan coverage assumption are established developments, while the September 11 close is below the August 28 close. A daily close above the December 2025 high of $27.87 would contradict the assessment of stalled price confirmation. The forecast has low conviction because the latest close is near the existing $23.82 invalidation threshold and the next company earnings date remains unconfirmed.

Bullish and bearish views on EverQuote, Inc.

The model's bull view on EverQuote, Inc. (EVER), in brief: Revenue expansion is already measured. The August 3 results showed second-quarter revenue growth of 25% year over year. The continuation case fails fundamentally if third-quarter revenue falls below management’s $198 million guidance floor. Company results. Analyst support has a… The bear view: Profit growth is not assured. The August 3 third-quarter adjusted EBITDA guidance of $28–31 million brackets the second-quarter result of $30.1 million. An outcome below $28 million would invalidate the profit component of the continuation thesis. Company results. Auto dominates… Both cases follow in full.

Bull Case

• Revenue expansion is already measured. The August 3 results showed second-quarter revenue growth of 25% year over year. The continuation case fails fundamentally if third-quarter revenue falls below management’s $198 million guidance floor. Company results.
• Analyst support has a date. JPMorgan assumed coverage at Overweight with a $29 analyst price target on August 24, according to StockStory and Benzinga reporting cited in the August 30 dossier. This establishes a third-party valuation view; it does not establish subsequent demand for the shares.

Bear Case

• Profit growth is not assured. The August 3 third-quarter adjusted EBITDA guidance of $28–31 million brackets the second-quarter result of $30.1 million. An outcome below $28 million would invalidate the profit component of the continuation thesis. Company results.
• Auto dominates the revenue mix. Second-quarter auto revenue was $172.1 million, compared with $23.0 million from home and renters insurance, in the August 3 release. The inferred vulnerability is a contraction in auto customer-acquisition spending; a subsequent decline in reported auto revenue would confirm that exposure becoming an operating problem. Company results.

Setup & Price Structure

The September 11, 2026 adjusted daily series records a $23.98 close, a 20.0% three-month price increase and a price 14.0% below the $27.87 trailing-year high. The 14-period relative strength index (RSI) was 42.8. These observations describe a positive three-month change alongside weaker recent momentum; they do not establish a completed base.

The $23.82 June swing-high shelf remains the research threshold identified in the August 30 publication. The September 11 close is above that threshold, but the available observations do not establish whether every intervening weekly close held it.

Positioning evidence remains historical: August 25 Form 4 transactions by director John L. Shields and technology chief David Brainard were reported under prearranged Rule 10b5-1 plans in the August 30 dossier. Those filings document scheduled insider transactions, not the cause of September’s price weakness. No current moving-average distance, short-interest series or systematic retail-sentiment sample is available; the evidence does not support a crowding verdict.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Third-quarter period end. This closes the reporting period covered by EverQuote’s August 3 guidance. It is a calendar boundary, not an announced results release.

No upcoming EverQuote corporate event was listed in the event calendar checked September 13. The next earnings date is unconfirmed, so no estimated November date is promoted to a company commitment. Corporate event calendar.

Elapsed catalysts

• 2026-09-18 — Progressive August results. Progressive’s investor calendar lists this release date, replacing the earlier September 16 estimate. It provides an external observation of carrier conditions; it cannot resolve EverQuote’s own revenue outcome. Progressive investor calendar. (passed 2d ago)

What Would Change Our Mind

Loss of the June shelf would end the price-continuation thesis: a weekly close below $23.82 is the observable invalidation. A daily close above the December 2025 high of $27.87 before that breach would satisfy its price test. Third-quarter revenue below $198 million or adjusted EBITDA below $28 million would separately break the operating case against the guidance issued August 3.

Correlation Notes

This remains a single-name insurance-advertising thesis. The August 3 revenue breakdown supports an economic connection to auto-insurance acquisition budgets, while Progressive’s September 18 release offers an adjacent industry observation. No paired return series is available to establish a measured correlation with Progressive, Allstate or MediaAlpha; common industry exposure alone does not establish that their shares move together.